Zydus Cadila has received the final approval from USFDA for marketing Potassium Chloride Extended-Release Capsules USP, 8 mEq (600 mg) and 10 mEq (750 mg). This will be manufactured at the company’s formulations manufacturing facility at SEZ, Ahmedabad.